Form 4: Cyclo Therapeutics Director Sieger Markus Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Markus Sieger reports acquisition and disposal of Cyclo Therapeutics (CYTH) common stock related to director compensation.
Summary
- Director Markus Sieger filed a Form 4 reporting changes in beneficial ownership of Cyclo Therapeutics, Inc. (CYTH) common stock.
- On February 27, 2025, Sieger acquired 58,138 shares of common stock as compensation in lieu of cash, valued at $0 per share.
- These shares were granted as compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025.
- The number of shares was calculated based on a closing price of $0.77 per share on February 26, 2025.
- Following the transaction, Sieger directly owns 440,260 shares of Cyclo Therapeutics common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of director compensation. The acceptance of stock in lieu of cash is a mildly positive signal.
Positives
- The director's acceptance of stock in lieu of cash compensation demonstrates confidence in the company's future.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in their company's stock. This allows investors to monitor insider activity, which can provide insights into management's perspective on the company's prospects.
Stakeholder Impact
- Shareholders are informed about changes in insider ownership, which can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Closing price of $0.77 per share used to calculate the number of shares granted. |
| 02/27/2025 | Date of transaction: Acquisition of 58,138 shares of common stock. |
| 03/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.